Robust hierarchically organized whole-brain patterns of dysconnectivity in schizophrenia spectrum disorders observed after personalized intrinsic network topography.


Journal

Human brain mapping
ISSN: 1097-0193
Titre abrégé: Hum Brain Mapp
Pays: United States
ID NLM: 9419065

Informations de publication

Date de publication:
15 10 2023
Historique:
revised: 05 07 2023
received: 10 01 2023
accepted: 01 08 2023
medline: 18 9 2023
pubmed: 22 8 2023
entrez: 22 8 2023
Statut: ppublish

Résumé

Spatial patterns of brain functional connectivity can vary substantially at the individual level. Applying cortical surface-based approaches with individualized rather than group templates may accelerate the discovery of biological markers related to psychiatric disorders. We investigated cortico-subcortical networks from multi-cohort data in people with schizophrenia spectrum disorders (SSDs) and healthy controls (HC) using individualized connectivity profiles. We utilized resting-state and anatomical MRI data from n = 406 participants (n = 203 SSD, n = 203 HC) from four cohorts. Functional timeseries were extracted from previously defined intrinsic network subregions of the striatum, thalamus, and cerebellum as well as 80 cortical regions of interest, representing six intrinsic networks using (1) volume-based approaches, (2) a surface-based group atlas approaches, and (3) Personalized Intrinsic Network Topography (PINT). The correlations between all cortical networks and the expected subregions of the striatum, cerebellum, and thalamus were increased using a surface-based approach (Cohen's D volume vs. surface 0.27-1.00, all p < 10 Surface-based and individualized approaches can more sensitively delineate cortical network dysconnectivity differences in people with SSDs. These robust patterns of dysconnectivity were visibly organized in accordance with the cortical hierarchy, as predicted by computational models.

Sections du résumé

BACKGROUND
Spatial patterns of brain functional connectivity can vary substantially at the individual level. Applying cortical surface-based approaches with individualized rather than group templates may accelerate the discovery of biological markers related to psychiatric disorders. We investigated cortico-subcortical networks from multi-cohort data in people with schizophrenia spectrum disorders (SSDs) and healthy controls (HC) using individualized connectivity profiles.
METHODS
We utilized resting-state and anatomical MRI data from n = 406 participants (n = 203 SSD, n = 203 HC) from four cohorts. Functional timeseries were extracted from previously defined intrinsic network subregions of the striatum, thalamus, and cerebellum as well as 80 cortical regions of interest, representing six intrinsic networks using (1) volume-based approaches, (2) a surface-based group atlas approaches, and (3) Personalized Intrinsic Network Topography (PINT).
RESULTS
The correlations between all cortical networks and the expected subregions of the striatum, cerebellum, and thalamus were increased using a surface-based approach (Cohen's D volume vs. surface 0.27-1.00, all p < 10
CONCLUSION
Surface-based and individualized approaches can more sensitively delineate cortical network dysconnectivity differences in people with SSDs. These robust patterns of dysconnectivity were visibly organized in accordance with the cortical hierarchy, as predicted by computational models.

Identifiants

pubmed: 37605827
doi: 10.1002/hbm.26453
pmc: PMC10502662
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5153-5166

Subventions

Organisme : NIMH NIH HHS
ID : 1/3 R01 MH102324
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH102313
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024911
Pays : United States
Organisme : NIH HHS
ID : DP5 OD012109
Pays : United States
Organisme : NIMH NIH HHS
ID : P50MH080173
Pays : United States
Organisme : NINDS NIH HHS
ID : PL1 NS062410
Pays : United States
Organisme : NIH HHS
ID : 2P50AA012870-11
Pays : United States
Organisme : NIH HHS
ID : 1U01MH121766
Pays : United States
Organisme : NIH HHS
ID : DP5OD012109
Pays : United States
Organisme : NCRR NIH HHS
ID : P20 RR021938
Pays : United States
Organisme : NIDA NIH HHS
ID : RL1 DA024853
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH102324
Pays : United States
Organisme : NIH HHS
ID : 5R01MH112189
Pays : United States
Organisme : NIH HHS
ID : 5R01MH108590
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH102313
Pays : United States
Organisme : NIMH NIH HHS
ID : PL1 MH083271
Pays : United States
Organisme : NIMH NIH HHS
ID : RL1 MH083270
Pays : United States
Organisme : NIMH NIH HHS
ID : RL1 MH083269
Pays : United States
Organisme : NIDCR NIH HHS
ID : UL1 DE019580
Pays : United States
Organisme : NIMH NIH HHS
ID : P50 MH080173
Pays : United States
Organisme : NLM NIH HHS
ID : RL1 LM009833
Pays : United States
Organisme : NIMH NIH HHS
ID : RL1 MH083268
Pays : United States
Organisme : NIAAA NIH HHS
ID : P50 AA012870
Pays : United States

Informations de copyright

© 2023 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.

Références

JAMA Psychiatry. 2015 Aug;72(8):767-77
pubmed: 26061743
Clin Neurosci. 1995;3(2):89-97
pubmed: 7583624
Front Neuroinform. 2011 Aug 22;5:13
pubmed: 21897815
Sci Transl Med. 2019 Feb 27;11(481):
pubmed: 30814340
PLoS One. 2017 Sep 25;12(9):e0184661
pubmed: 28945803
Nat Commun. 2018 Mar 20;9(1):1157
pubmed: 29559638
Biol Psychiatry. 2018 Sep 15;84(6):452-459
pubmed: 29779670
J Neurophysiol. 2011 Sep;106(3):1125-65
pubmed: 21653723
Biol Psychiatry. 2018 Mar 15;83(6):473-474
pubmed: 29429501
Nat Neurosci. 2015 Dec;18(12):1853-60
pubmed: 26551545
PLoS One. 2016 Mar 30;11(3):e0152472
pubmed: 27027775
Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6356-E6365
pubmed: 29925602
Neuroinformatics. 2017 Oct;15(4):343-364
pubmed: 28812221
Mol Psychiatry. 2013 Nov;18(11):1199-204
pubmed: 23337947
Schizophr Bull. 2020 Mar 07;:
pubmed: 32144421
Front Psychiatry. 2019 Jul 12;10:482
pubmed: 31354545
Front Neuroinform. 2014 Feb 21;8:14
pubmed: 24600388
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Sep;3(9):777-787
pubmed: 30093344
Hum Brain Mapp. 2018 Nov;39(11):4213-4227
pubmed: 29962049
Nat Methods. 2019 Jan;16(1):111-116
pubmed: 30532080
Schizophr Bull. 2021 Apr 29;47(3):837-848
pubmed: 33135075
Schizophr Bull. 2021 Jan 23;47(1):180-188
pubmed: 32648915
Biol Psychiatry. 2018 Nov 1;84(9):665-674
pubmed: 29779671
Nat Protoc. 2018 Dec;13(12):2801-2826
pubmed: 30446748
Cereb Cortex. 2019 Dec 17;29(11):4463-4487
pubmed: 31157363
Neuroimage. 2013 Oct 15;80:105-24
pubmed: 23668970
Am J Psychiatry. 2012 Oct;169(10):1092-9
pubmed: 23032387
Schizophr Bull. 2019 Sep 11;45(5):1143-1151
pubmed: 30500946
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Nov;4(11):956-965
pubmed: 31399394
J Neurophysiol. 2012 Oct;108(8):2242-63
pubmed: 22832566
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Neuroimage. 2008 Jul 1;41(3):835-48
pubmed: 18434199
Biol Psychiatry. 2018 Aug 15;84(4):278-286
pubmed: 29703592
Front Behav Neurosci. 2015 Feb 25;9:45
pubmed: 25762911
Br J Psychiatry. 2011 Mar;198(3):173-5
pubmed: 21357874
Mol Psychiatry. 2020 Sep;25(9):2119-2129
pubmed: 30443042
Neuroimage. 2019 Apr 15;190:182-190
pubmed: 29355768
Cereb Cortex. 2018 Sep 1;28(9):3095-3114
pubmed: 28981612
J Neurophysiol. 2011 Nov;106(5):2322-45
pubmed: 21795627
Schizophr Res. 2022 Oct;248:21-31
pubmed: 35908378
Neuroimage. 2018 May 1;171:415-436
pubmed: 29278773
Neuroimage. 2014 Aug 15;97:117-26
pubmed: 24736181
Comput Biomed Res. 1996 Jun;29(3):162-73
pubmed: 8812068
Sci Data. 2016 Dec 06;3:160110
pubmed: 27922632
Nat Commun. 2018 Sep 21;9(1):3836
pubmed: 30242220
Nat Med. 2020 Apr;26(4):558-565
pubmed: 32251404
Neuroimage. 2014 Jan 1;84:320-41
pubmed: 23994314
Neuroimage. 2012 Oct 1;62(4):2296-314
pubmed: 22387165
Schizophr Res. 2014 Dec;160(1-3):67-72
pubmed: 25445623
Am J Psychiatry. 2019 Jul 1;176(7):512-520
pubmed: 30696271
Nat Neurosci. 2015 Feb;18(2):302-9
pubmed: 25599222
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1279-84
pubmed: 19164577
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
Neuroimage. 2002 Oct;17(2):825-41
pubmed: 12377157
Hum Brain Mapp. 2023 Oct 15;44(15):5153-5166
pubmed: 37605827
Arch Clin Neuropsychol. 2002 Jul;17(5):461-75
pubmed: 14592000
Neuropsychopharmacology. 2018 Oct;43(11):2239-2248
pubmed: 29899404
Neuroimage. 2014 Oct 15;100:414-26
pubmed: 24939340
Cereb Cortex. 2019 Jun 1;29(6):2533-2551
pubmed: 29878084
Neuroimage. 2009 Oct 15;48(1):63-72
pubmed: 19573611
Elife. 2018 Feb 16;7:
pubmed: 29451491
Schizophr Bull. 2018 Jan 13;44(1):168-181
pubmed: 28338943
Neuron. 2017 Aug 16;95(4):791-807.e7
pubmed: 28757305
Neuroimage. 2019 Aug 15;197:818-826
pubmed: 31091476
Schizophr Res. 2017 Feb;180:58-63
pubmed: 27531067
JAMA Psychiatry. 2018 Jun 1;75(6):613-622
pubmed: 29710118
Neuropsychopharmacology. 2019 Aug;44(9):1649-1658
pubmed: 31060043
Neuroimage. 2019 Jan 15;185:35-57
pubmed: 30291974
Neurosci Biobehav Rev. 2011 Apr;35(5):1110-24
pubmed: 21115039
JAMA Psychiatry. 2015 Sep;72(9):882-91
pubmed: 26267151
Front Neuroinform. 2017 Feb 21;11:17
pubmed: 28270762
JAMA Psychiatry. 2015 Jan;72(1):5-13
pubmed: 25372846
Nat Neurosci. 2016 Aug 26;19(9):1175-87
pubmed: 27571196

Auteurs

Erin W Dickie (EW)

Center for Addiction and Mental Health, Campbell Family Mental Health Research, Toronto, Ontario, Canada.
Department of Psychiatry, University of Toronto, Toronto, Ontario, USA.

Saba Shahab (S)

Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Colin Hawco (C)

Center for Addiction and Mental Health, Campbell Family Mental Health Research, Toronto, Ontario, Canada.
Department of Psychiatry, University of Toronto, Toronto, Ontario, USA.

Dayton Miranda (D)

Center for Addiction and Mental Health, Campbell Family Mental Health Research, Toronto, Ontario, Canada.

Gabrielle Herman (G)

Center for Addiction and Mental Health, Campbell Family Mental Health Research, Toronto, Ontario, Canada.

Miklos Argyelan (M)

Psychiatry Research, The Zucker Hillside Hospital, Glen Cove, New York, USA.
Institute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.

Jie Lisa Ji (JL)

Department of Psychiatry, Yale University, New Haven, Connecticut, USA.

Jerrold Jeyachandra (J)

Center for Addiction and Mental Health, Campbell Family Mental Health Research, Toronto, Ontario, Canada.

Alan Anticevic (A)

Department of Psychiatry, Yale University, New Haven, Connecticut, USA.

Anil K Malhotra (AK)

Psychiatry Research, The Zucker Hillside Hospital, Glen Cove, New York, USA.
Institute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, New York, USA.
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.

Aristotle N Voineskos (AN)

Center for Addiction and Mental Health, Campbell Family Mental Health Research, Toronto, Ontario, Canada.
Department of Psychiatry, University of Toronto, Toronto, Ontario, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH